Sublingual immunotherapy approved for grass pollen allergies
The FDA recently announced its approval of a sublingual alternative to immunotherapy injections for people 10 to 65 years of age who are allergic to sweet vernalgrass, orchardgrass, perennial ryegrass, timothy or Kentucky bluegrass. Each tablet, the agency said, contains freeze-dried pollen extracts of those five perennial grasses.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063